Introduction to Personalised Medicine

Learn the basics about potential and principles in genetically based treatments

  • access anytime

7 session course

English

7.000,- DKK ex VAT
(app. 941,- EUR ex VAT)
50% DISCOUNT FOR PUBLIC INSTITUTIONS

Summary

Personalised Medicine supports patients in receiving an optimal and effective treatment with a minimum of risk of adverse events.

As this type of treatment is still relatively new, many have the need for an introduction to the basics of personalised medicine: what is the potential? What types of analyses are needed? What is the flow in collaboration and responsibilities among stakeholders, e.g. doctors, analysts and patients?

By completing the 7 modules included in this self-access online course, you acquire basic knowledge about personalised medicine: The potential of genetic analysis of drug metabolising enzymes, transporters and receptors, and how to use this information in clinical practice.

You can access the 7 online modules whenever is most convenient for you. Please note that your access expires one year from the time you sign up.

After finishing each module, you must answer a number of questions related to that specific module before you can access the next module.

After completing the 7 modules, you have the possibility to join 3 online follow-up Q&A sessions with the experts who prepared the modules. You will be able to sign up for 3 sessions of 1 hours duration within a year from your completion of the 7 modules. The Q&A sessions are based on your questions and are included in the course price.

 

Key words

  • Personalised medicine
  • Optimised medical treatment
  • Reduction of adverse events
  • Pharmacogenomics
  • Pharmacokinetics
  • Pharmacodynamics

What you will learn

  1. Module 1: How pharmacogenomic testing can support the healthcare system in providing the right medical treatment, to the right patient, in the right dose, at the right time.
  2. Module 2: Legal aspects in relation to ethics and GDPR.
  3. Module 3: How pharmacogenomic data can be translated and applied in the clinic. And the internationally peer-reviewed pharmacogenetic databases, treatment guidelines and regulatory framework that will guide your way.
  4. Module 4: Factors beyond pharmacokinetics and pharmacodynamics, e.g. how genetic variation can help shed light on different responses to drugs between patients.
  5. Module 5: The analytical aspects in the laboratory: what is the laboratory process flow? How is the genotype translated into the phenotype? What are the limitations and advantages of several platforms?
  6. Module 6: Pharmacogenomics is not something in the future – it is here today. Patients can already benefit from personalised medicine, e.g. capecitabine/DPYD, clopidogrel/CYP2C19, antidepressants/CYP2D6, pain/CYP2D6 and more.
  7. Module 7: Pharmacogenomics is only one factor that affects the dose-response relationship of drugs. Co-medication, kidney function, lifestyle etc. are well-known contributors affecting the dose-response relationship of drugs.

What your company will get

  1. An employee with an understanding of personalised medicine in relation to pharmacogenomics, pharmacokinetics and pharmacodynamics, legal aspects, regulatory framework and clinical utility.

Want to know more about this course?

Contact Client Manager Christina Spangsberg at +45 39 15 09 22

Send a message

You may also be interested in these courses